Schizophrenia (cont.)

Medical Author:
Medical Editor:

Where can people get more information about schizophrenia?

NARSAD
800-829-8289

National Institute of Mental Health
9000 Rockville Pike
Bethesda, Maryland 20892
NIHinfo@od.nih.gov
301-496-4000

NAMI (National Alliance on Mental Illness)
http://www.nami.org/

Marina Katz, MD; American Board of Psychiatry & Neurology

REFERENCES:

Addington, A.M., M. Gornick, J. Duckworth, et al. "GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD-67), is associated with childhood onset schizophrenia and cortical gray matter volume loss." Molecular Psychiatry 10 (2005): 581-588.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; Washington, D.C.: American Psychiatric Association, 2000.

Baker, F.M., and C.C. Bell. "Issues in the psychiatric treatment of African Americans." Psychiatric Services 50 Mar. 1999: 362-368.

Beresford, C., S. Hepburn, and R.G. Ross. "Follow-up for 6 and 8 years." Clinical Child Psychology and Psychiatry 10 (2005): 429-439.

Bond, G. "Assertive community treatment for people with severe mental illness." Indiana University-Purdue University Indianapolis Mar. 2002. Indianapolis, Indiana.

Cascade, E.F., A.H. Kalali, and P.F. Buckley. "Current management of schizophrenia: Antipsychotic monotherapy versus combination therapy." Psychiatry 5.5 May 2008: 28-30.

Chanpattanaa, W., and M.L.S. Chakrabhandb. "Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome." Psychiatry Research 105.1 Dec. 2001: 107-115.

Dixon, L., D. Perkins, and C. Calmes. "Guideline Watch: Practice Guideline for the Treatment of Patients With Schizophrenia." PsychiatryOnline.com. Sept. 2009. <http://www.psychiatryonline.com/content.aspx?aid=501001>.

Friedman, J.I., T. Vrijenhoek, S. Markx, et al. "CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy." Molecular Psychiatry 13 Mar. 2008: 261-266.

Gentile, S. "Antipsychotic therapy during early and late pregnancy. A systemic review." Oxford University Press, 2008.

Hedgecoe, A. "Schizophrenia and the narrative of enlightened geneticazation." Social Studies of Science 31 (2001): 875.

Hollis, C. "Developmental precursors of child- and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions." The British Journal of Psychiatry 182 (2003): 37-44.

Khorrami, S. "Genius, madness, and masculinity: A beautiful mind examined through a men's issue model." Men and Masculinities 5 (2002): 116.

Kyziridis, T.C. "Notes on the history of schizophrenia." German Journal of Psychiatry 8 (2005): 42-48.

Lin, K.M, and F. Cheung. "Mental health issues for Asian Americans." Psychiatric Services 50 June 1999: 774-780.

Marin, H. "Hispanics and psychiatric medications: An overview." Psychiatric Times 20.10 Oct. 2003.

Mattai, A.K., J.L. Hill, and R.K. Lenroot. "Treatment of early onset schizophrenia." Current Opinion in Psychiatry 23 July 2010.

McGrath, J., S. Saha, D. Chant, and J. Welham. "Schizophrenia: A concise overview of incidence, prevalence and mortality." Epidemiologic Reviews 30.1 (2008): 67-76.

McGurk, S.R., K.T. Mueser, P.D. Harvey, et al. "Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment." Psychiatric Services 54 Aug. 2003: 1129-1135.

Meyer, I.H. "Prejudice, social stress and mental health in lesbian, gay and bisexual populations: conceptual issues and research evidence." Psychological Bulletin 129.5 (2003): 674-697.

Newcomer, J.W. "Metabolic risk during antipsychotic treatment." Clinical Therapeutics 26.12 Dec. 2004: 1936-1946.

President and Fellows of Harvard College. "Schizophrenia and Bipolar Disorder May Share Genetic Origins." Harvard Mental Health Lett 25.12 June 2009: 7.

Read, J., and R. Bentall. "Schizophrenia and childhood adversity." American Journal of Psychiatry 167 June 2010: 717-718.

Sorensen, H.J., E.L. Mortensen, J.M. Reinisch, and S.A. Mednick. "Association between prenatal exposure to bacterial infection and risk of schizophrenia." Schizophrenia Bulletin 35.3 May 2009: 631-637.

Veling, W., E. Susser, J. van Os, J.P. Mackenbach, et al. "Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants." American Journal of Psychiatry Dec. 2007: 1-8.

Velligan, D.I., and L.D. Alphs. "Negative symptoms in schizophrenia: the importance of identification and treatment." Psychiatric Times 25.3 Mar. 2008.

Volkow, N.D. "Substance use disorders in schizophrenia: Clinical implications of comorbidity." Schizophrenia Bulletin 35.3 May 2009: 469-472.

Wasserman, S., A. Weisman de Mamani, and P. Mundy. "Parents' criticisms and attributions about their adult children with high functioning autism or schizophrenia." Autism 14 (2010): 127-138.


Medically Reviewed by a Doctor on 4/11/2014

Patient Comments

Viewers share their comments

Schizophrenia - Describe Your Experience Question: Please describe your experience with schizophrenia.
Schizophrenia - Treatments Question: What treatments have been effective for your schizophrenia?
Schizophrenia - In Children Question: What were your child's symptoms of shizophrenia? Please share your story.
Schizophrenia - Symptoms Question: Describe the symptoms associated with schizophrenia in you, a friend, or relative.

STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!